Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies

202131 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: European Journal of Cancer

Volume 153, pp. 142-152

Field-Weighted Citation Impact: 1.78